Zacks Investment Research upgraded shares of Calyxt (NASDAQ:CLXT) from a sell rating to a hold rating in a research note issued to investors on Monday morning.

According to Zacks, “Calyxt, Inc. is a consumer-centric, food- and agriculture-focused company. It researches and develops seeds and food ingredients for agricultural, feed, and food applications as well as offers fat saturation and gluten reduction in soybean oil and wheat. Calyxt, Inc. is based in New Brighton, United States. “

Several other research analysts also recently weighed in on the company. Ladenburg Thalmann Financial Services assumed coverage on Calyxt in a research note on Wednesday, December 20th. They set a buy rating and a $34.25 target price for the company. Citigroup reduced their target price on Calyxt from $27.00 to $22.00 and set a neutral rating for the company in a research note on Thursday, November 16th. Jefferies Group upped their target price on Calyxt to $27.00 and gave the stock a buy rating in a research note on Wednesday, November 1st. BMO Capital Markets assumed coverage on Calyxt in a research note on Monday, October 30th. They set an outperform rating and a $32.00 target price for the company. Finally, Wells Fargo & Co upped their target price on Calyxt from $17.00 to $30.00 and gave the stock an outperform rating in a research note on Friday, September 29th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. Calyxt has a consensus rating of Buy and an average price target of $29.05.

Shares of Calyxt (NASDAQ CLXT) traded up $0.28 during mid-day trading on Monday, hitting $23.37. The stock had a trading volume of 40,220 shares, compared to its average volume of 67,550. The company has a current ratio of 12.41, a quick ratio of 12.41 and a debt-to-equity ratio of 0.13. The firm has a market cap of $639.43 and a P/E ratio of -25.68. Calyxt has a twelve month low of $9.26 and a twelve month high of $31.89.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp acquired a new position in Calyxt in the 3rd quarter valued at $542,000. Schwab Charles Investment Management Inc. acquired a new position in Calyxt in the 3rd quarter valued at $358,000. California State Teachers Retirement System acquired a new position in Calyxt in the 3rd quarter valued at $323,000. Finally, American International Group Inc. acquired a new position in Calyxt in the 3rd quarter valued at $133,000. 21.13% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Calyxt (CLXT) Upgraded at Zacks Investment Research” was first posted by Watch List News and is the property of of Watch List News. If you are accessing this story on another publication, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this story can be read at https://www.watchlistnews.com/calyxt-clxt-upgraded-at-zacks-investment-research/1800492.html.

About Calyxt

Calyxt, Inc is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics.

Get a free copy of the Zacks research report on Calyxt (CLXT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Analyst Recommendations for Calyxt (NASDAQ:CLXT)

Receive News & Ratings for Calyxt Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calyxt and related companies with MarketBeat.com's FREE daily email newsletter.